Wednesday, October 16, 2024
No menu items!
HomePfizer sees steep 2023 fall in COVID sales, aims to bolster pipelineFILE PHOTO: Paxlovid is shown in this picture illustration

FILE PHOTO: Paxlovid is shown in this picture illustration

FILE PHOTO: Paxlovid, Pfizer's anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration taken October 7, 2022. REUTERS/Wolfgang Rattay/Illustration/File Photo
COVID-19 vaccination center in Nice
Pfizer spending billions to expand European manufacturing
- Advertisment -

Most Read